Krystal Biotech, Inc. (KRYS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Krystal Biotech, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 34.84x | 50.24x | 308.15x | -14.43x | -22.32x | -35.04x |
| P/B Ratio | 5.85x | 4.73x | 4.33x | 3.87x | 2.62x | 3.86x |
| P/S Ratio | 18.34x | 15.42x | 66.45x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 92.6% | 93.1% | 93.9% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 41.5% | 22.6% | -216.4% | 0.0% | 0.0% | 0.0% |
| Net Margin | 52.6% | 30.7% | 21.6% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 43.1% | 37.8% | -180.1% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 9.95x | 7.28x | 17.76x | 13.30x | 17.18x | 17.80x |
| Quick Ratio | 9.56x | 7.02x | 17.55x | 13.30x | 17.18x | 17.80x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.01x | 0.04x |
YoY = year-over-year change. Source: FMP..